Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTC13 Inhibitors

TTC13 inhibitors are a class of chemical compounds designed to selectively inhibit the TTC13 protein, a member of the tetratricopeptide repeat (TPR) domain-containing protein family. The TTC13 protein is involved in various cellular processes, particularly through its role in mediating protein-protein interactions. The TPR domains within TTC13 function as structural motifs that facilitate the assembly of multi-protein complexes, critical for regulating diverse intracellular signaling pathways and molecular interactions. TTC13 inhibitors work by binding to specific regions of the protein, such as its TPR domains, to prevent TTC13 from interacting with its natural protein partners. This disruption can alter cellular signaling pathways and the dynamics of protein complex formation, leading to a deeper understanding of TTC13's functional role within the cell.

Chemically, TTC13 inhibitors are often small molecules with distinct structural features that enable high specificity for the TTC13 protein. These compounds typically include a combination of hydrophobic groups, hydrogen bond donors, and acceptors, which allow for precise binding to TTC13's active or binding sites. In the development of TTC13 inhibitors, emphasis is placed on achieving a high degree of selectivity to avoid interference with other TPR-containing proteins, which share similar structural features but perform different cellular functions. By studying the interaction of these inhibitors with TTC13, researchers can explore the conformational changes and functional impacts on protein complexes. This research provides valuable insights into how TTC13 operates within broader cellular networks and contributes to regulatory processes, making TTC13 inhibitors a useful tool in understanding the molecular mechanics of TPR domain proteins.

SEE ALSO...

Items 11 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$92.00
$260.00
42
(2)

A cyclin-dependent kinase inhibitor, Roscovitine may indirectly inhibit TTLL13 by altering cell cycle regulation and affecting the availability and modification of tubulin, which is the substrate for TTLL13.